Glucose Health Statistics
Total Valuation
Glucose Health has a market cap or net worth of $5.80 million. The enterprise value is $5.61 million.
Market Cap | 5.80M |
Enterprise Value | 5.61M |
Important Dates
The last earnings date was Wednesday, February 8, 2023.
Earnings Date | Feb 8, 2023 |
Ex-Dividend Date | n/a |
Share Statistics
Glucose Health has 17.01 million shares outstanding. The number of shares has increased by 0.22% in one year.
Shares Outstanding | 17.01M |
Shares Change (YoY) | +0.22% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 5.11% |
Owned by Institutions (%) | n/a |
Float | 8.27M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 11.14 |
Forward PS | n/a |
PB Ratio | 23.33 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 10.77 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.10, with zero debt.
Current Ratio | 3.10 |
Quick Ratio | 1.86 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -146.99% and return on invested capital (ROIC) is -146.99%.
Return on Equity (ROE) | -146.99% |
Return on Assets (ROA) | -99.95% |
Return on Capital (ROIC) | -146.99% |
Revenue Per Employee | $173,505 |
Profits Per Employee | -$121,847 |
Employee Count | 3 |
Asset Turnover | 1.51 |
Inventory Turnover | 1.60 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -12.11% in the last 52 weeks. The beta is 3.50, so Glucose Health's price volatility has been higher than the market average.
Beta (1Y) | 3.50 |
52-Week Price Change | -12.11% |
50-Day Moving Average | 0.47 |
200-Day Moving Average | 0.38 |
Relative Strength Index (RSI) | 42.65 |
Average Volume (30 Days) | 7,649 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Glucose Health had revenue of $520,515 and -$365,540 in losses. Loss per share was -$0.02.
Revenue | 520,515 |
Gross Profit | 218,208 |
Operating Income | -365,540 |
Pretax Income | -365,540 |
Net Income | -365,540 |
EBITDA | -365,540 |
EBIT | n/a |
Loss Per Share | -$0.02 |
Balance Sheet
The company has $193,529 in cash and no debt, giving a net cash position of $193,529 or $0.01 per share.
Cash & Cash Equivalents | 193,529 |
Total Debt | n/a |
Net Cash | 193,529 |
Net Cash Per Share | $0.01 |
Equity / Book Value | 248,683 |
Book Value Per Share | 0.01 |
Working Capital | 245,388 |
Cash Flow
Operating Cash Flow | -250,597 |
Capital Expenditures | n/a |
Free Cash Flow | -250,597 |
FCF Per Share | -$0.01 |
Margins
Gross margin is 41.92%, with operating and profit margins of -70.23% and -70.23%.
Gross Margin | 41.92% |
Operating Margin | -70.23% |
Pretax Margin | -70.23% |
Profit Margin | -70.23% |
EBITDA Margin | -70.23% |
EBIT Margin | n/a |
FCF Margin | -48.14% |
Dividends & Yields
Glucose Health does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.22% |
Shareholder Yield | -0.22% |
Earnings Yield | -6.30% |
FCF Yield | -4.32% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on November 17, 2014. It was a reverse split with a ratio of 1:50.
Last Split Date | Nov 17, 2014 |
Split Type | Reverse |
Split Ratio | 1:50 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 3 |